{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:45:40Z","timestamp":1792183540454,"version":"4.4.0"},"reference-count":34,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"10","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Precis Oncol"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Immunotherapy with chemotherapy significantly improves progression-free survival in advanced endometrial cancer (EC), especially in microsatellite instability-high (MSI-H) cases. Despite this, for recurrent EC in the postimmunotherapy setting, new treatment options are urgently needed. The PI3K pathway is frequently altered in gynecologic cancers, including EC, representing a potential treatment target.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>\n                      In a preplanned translational analysis of the MITO END-3, we retrospectively analyzed the genomic abnormalities of 107 patients with samples eligible for next-generation sequencing (NGS) analysis (FoundationOne CDx) with a focus on\n                      <jats:italic toggle=\"yes\">PIK3CA<\/jats:italic>\n                      mutational status.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In our analysis, the four most frequently mutated genes were\n                      <jats:italic toggle=\"yes\">TP53<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">PIK3CA<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">ARID1A<\/jats:italic>\n                      , and\n                      <jats:italic toggle=\"yes\">PTEN. PIK3CA<\/jats:italic>\n                      mutations were detected in 51.4% (55\/107 patients) of tissue samples. A total of 68 different\n                      <jats:italic toggle=\"yes\">PIK3CA<\/jats:italic>\n                      mutations were observed, of which 64 were considered pathogenic and four were classified as variants of unknown significance, with the co-occurrence of two different pathogenic mutations in 2 patients. The most frequent\n                      <jats:italic toggle=\"yes\">PIK3CA<\/jats:italic>\n                      mutations were found in the kinase domain, most commonly H1047R (11\/68) and H1047Y (3\/68), and in the helical domain, including E545K (4\/68) and E542K (3\/68). Notably, 24 different\n                      <jats:italic toggle=\"yes\">PIK3CA<\/jats:italic>\n                      mutations out of 68 reported in MITO END-3 are considered predictive of response to PI3K inhibition with alpelisib according to current literature in breast cancer. Interestingly,\n                      <jats:italic toggle=\"yes\">PIK3CA<\/jats:italic>\n                      mutations were observed in all The Cancer Genome Atlas categories.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      In this post hoc analysis from the MITO END-3 trial, we confirmed the high frequency of\n                      <jats:italic toggle=\"yes\">PIK3CA<\/jats:italic>\n                      mutations in EC, establishing this tumor as an ideal candidate for testing of PI3K inhibitors in clinical trials.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/po-26-00484","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:59:09Z","timestamp":1792180749000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["<i>PIK3CA<\/i>\n                    Mutations in Advanced or Recurrent Endometrial Cancer: An Exploratory Molecular Profiling From the Phase II MITO END-3 Study"],"prefix":"10.1200","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4643-7809","authenticated-orcid":true,"given":"Anna","family":"Passarelli","sequence":"first","affiliation":[{"name":"Uro-Gynecological Medical Oncology, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5622-7843","authenticated-orcid":true,"given":"Giovanni Luca","family":"Scaglione","sequence":"additional","affiliation":[{"name":"Bioinformatics Unit, Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6945-3209","authenticated-orcid":true,"given":"Daniela","family":"Califano","sequence":"additional","affiliation":[{"name":"Microenvironment Molecular Targets Unit, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9631-5693","authenticated-orcid":true,"given":"Michele","family":"Bartoletti","sequence":"additional","affiliation":[{"name":"Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0981-0598","authenticated-orcid":true,"given":"Domenica","family":"Lorusso","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Humanitas San Pio X, Milan, Italy"},{"name":"Department of Biomedical Sciences, Humanitas University, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina Chiara","family":"Cecere","sequence":"additional","affiliation":[{"name":"Uro-Gynecological Medical Oncology, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5579-335X","authenticated-orcid":true,"given":"Anna","family":"Fagotti","sequence":"additional","affiliation":[{"name":"Dipartimento Scienze della Salute della Donna, del Bambino e di Sanit\u00e0 Pubblica, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3289-8041","authenticated-orcid":true,"given":"Alberto","family":"Farolfi","sequence":"additional","affiliation":[{"name":"Medical Oncology, Breast &amp; GYN Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0470-043X","authenticated-orcid":true,"given":"Claudia","family":"Andreetta","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, \u201cS. Maria della Misericordia\u201d University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jole","family":"Ventriglia","sequence":"additional","affiliation":[{"name":"Uro-Gynecological Medical Oncology, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Arenare","sequence":"additional","affiliation":[{"name":"Clinical Trial Unit, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Pisano","sequence":"additional","affiliation":[{"name":"Uro-Gynecological Medical Oncology, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Russo","sequence":"additional","affiliation":[{"name":"Microenvironment Molecular Targets Unit, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Perri","sequence":"additional","affiliation":[{"name":"Dipartimento Scienze della Salute della Donna, del Bambino e di Sanit\u00e0 Pubblica, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saverio","family":"Cinieri","sequence":"additional","affiliation":[{"name":"U.O.C. Oncologia Medica-Ospedale Senatore Antonio Perrino, Brindisi, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Scalone","sequence":"additional","affiliation":[{"name":"Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7520-2908","authenticated-orcid":true,"given":"Ugo","family":"De Giorgi","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, University of Salento, Fazzi Hospital, Lecce, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Arcangeli","sequence":"additional","affiliation":[{"name":"Romagna Cancer Registry IRCCS Istituto Romagnolo per lo Studio dei Tumori \u201cDino Amadori\u201d (IRST), Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Zafarana","sequence":"additional","affiliation":[{"name":"Department of Oncology, Hospital of Prato Azienda USL Toscana Centro, Prato, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Cannizzaro","sequence":"additional","affiliation":[{"name":"Dipartimento Scienze della Salute della Donna, del Bambino e di Sanit\u00e0 Pubblica, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6560-0061","authenticated-orcid":true,"given":"Serafina","family":"Mammoliti","sequence":"additional","affiliation":[{"name":"AOM Liguria, Azienda Ospedaliera Metropolitana di Genova, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Ambrosio","sequence":"additional","affiliation":[{"name":"Microenvironment Molecular Targets Unit, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"De Cecio","sequence":"additional","affiliation":[{"name":"Division of Anatomic Pathology and Cytopathology, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clorinda","family":"Schettino","sequence":"additional","affiliation":[{"name":"Clinical Trial Unit, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9738-0526","authenticated-orcid":true,"given":"Francesco","family":"Perrone","sequence":"additional","affiliation":[{"name":"Clinical Trial Unit, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8836-2633","authenticated-orcid":true,"given":"Sandro","family":"Pignata","sequence":"additional","affiliation":[{"name":"Uro-Gynecological Medical Oncology, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_3_6_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2020-002230"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(83)90111-7"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2024.104555"},{"key":"e_1_3_6_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature12113"},{"key":"e_1_3_6_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx753"},{"key":"e_1_3_6_8_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00549"},{"key":"e_1_3_6_9_2","doi-asserted-by":"publisher","DOI":"10.14694\/EdBook_AM.2013.33.e218"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2018.28"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2019.100532"},{"key":"e_1_3_6_12_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-0662"},{"key":"e_1_3_6_13_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2878"},{"key":"e_1_3_6_14_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095219"},{"key":"e_1_3_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2005.10.003"},{"key":"e_1_3_6_16_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16761"},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008000"},{"key":"e_1_3_6_18_2","first-page":"3485","article-title":"PTEN gene mutations correlate to poor prognosis in glioma patients: A meta-analysis","volume":"9","author":"Han F","year":"2016","unstructured":"Han F, Hu R, Yang H, et al: PTEN gene mutations correlate to poor prognosis in glioma patients: A meta-analysis. Onco Targets Ther 9:3485-3492, 2016","journal-title":"Onco Targets Ther"},{"key":"e_1_3_6_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1813904"},{"key":"e_1_3_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00034-6"},{"key":"e_1_3_6_21_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.72.7107"},{"key":"e_1_3_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00016-5"},{"key":"e_1_3_6_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003777"},{"key":"e_1_3_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.04.007"},{"key":"e_1_3_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2025.105919"},{"key":"e_1_3_6_26_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1088962"},{"key":"e_1_3_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2024.02.029"},{"key":"e_1_3_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2025.105755"},{"key":"e_1_3_6_29_2","volume-title":"ASCO","author":"Rugo HS","year":"2021","unstructured":"Rugo HS, Raskina K, Schrock AB, et al: ASCO, 2021; June 4-7, Poster 1068"},{"key":"e_1_3_6_30_2","doi-asserted-by":"crossref","unstructured":"Juric D Andr\u00e9 F Singer CF et al: Poster P4-10-04. Abstract P4-10-04: Clinical outcomes of alpelisib in hormone receptor-positive human epidermal growth factor receptor-2-negative advanced breast cancer by next-generation sequencing-detected PIK3CA alteration status and phosphatase and tensin homolog loss: Biomarker analysis from the SOLAR-1 study. SABCS. 2019","DOI":"10.1158\/1538-7445.SABCS19-P4-10-04"},{"key":"e_1_3_6_31_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-2620"},{"key":"e_1_3_6_32_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-1170"},{"key":"e_1_3_6_33_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472-CAN-04-3913"},{"key":"e_1_3_6_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2404625"},{"key":"e_1_3_6_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2214131"}],"container-title":["JCO Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/PO-26-00484","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:59:16Z","timestamp":1792180756000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/PO-26-00484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1200\/PO-26-00484"],"URL":"https:\/\/doi.org\/10.1200\/po-26-00484","relation":{},"ISSN":["2473-4284"],"issn-type":[{"value":"2473-4284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"2026-04-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2600484"}}